Spiro-fused pyrrolidine derivatives as desubiquitination (DUB) enzyme inhibitors
MA43701AUndetermined Publication Date: 2018-11-28MISSION THERAPEUTICS LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA43701
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2016-03-04
- Filing Date
- 2017-03-02
- Publication Date
- 2018-11-28
Need to check novelty before this filing date? Find Prior Art
No text content released.